logo
  

Health Insurance Says Total Approved Applications Received In Q3 Surge 82%

Health Insurance Innovations, Inc. (HIIQ), a developer and administrator of affordable, cloud-based individual health insurance plans and ancillary products, said total approved applications received in the third quarter of 2014 increased 82 percent from last year.

Core medical application count increased 48 percent, and ancillary application count increased 158 percent, respectively, during the quarter.

Approved applications convert to insurance policies in force at a reliably high rate and drive revenue over the entire period of the policy. The resulting growth in policies in force increases revenues during both the quarter the policies are issued and in subsequent quarters, the company said.

In addition, HealthPocket.com, the recently acquired health insurance search and comparison technology company, grew third quarter targeted referrals by more than double the second quarter level.

Mike Kosloske, HII's Chairman and CEO, said, "HII's continued strong growth outside of the Affordable Care Act open enrollment period highlights our ability to provide attractive products to the consumer at affordable prices... .We now expect to exceed our annual 2014 revenue guidance of at least 45% growth vs. 2013."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT